We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEED:NASDAQOrigin Agritech Limited Analysis

Data as of 2026-05-26 - not real-time

$1.13

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Origin Agritech Limited is trading well below its 20‑day SMA of $1.15 and under its 50‑day SMA of $1.22, signaling a bearish price bias. The RSI sits at 42, just below the neutral zone, while the MACD line is marginally under its signal, reinforcing short‑term downside momentum. Volatility is extreme at 44% over the past 30 days and the beta, while sub‑1 in the computed model, still reflects heightened sensitivity to market swings. Fundamentals are weak: revenue has plunged 31.9% year‑over‑year, gross margin is a meager 5.6%, and operating margins are deeply negative at –26%, with a negative book value per share and a –3.9 PB ratio. Cash generation is negative, with operating cash flow of –$12.9 M and free cash flow of –$4.8 M, while debt of $46.6 M dwarfs the $13.4 M cash balance. The company carries no dividend and faces pronounced regulatory and geographic headwinds in China’s biotech seed sector. Liquidity is constrained, evidenced by a decreasing volume trend and a market cap of only $13.7 M. Despite an “Extreme Greed” sentiment index, the underlying financial health does not support speculative buying.
Given the confluence of bearish technicals, deteriorating fundamentals, high volatility, and sector‑specific risks, the stock appears undervalued from a price‑to‑sales perspective but carries substantial downside risk. Investors should approach with caution, limiting exposure unless a clear turnaround catalyst emerges.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below SMA, negative MACD)
  • Negative cash flow and high debt load
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential strategic collaborations with Chinese agricultural institutes
  • Continued revenue contraction and thin margins
  • Moderate sector cyclicality but persistent regulatory uncertainty

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental financial distress limits upside
  • Long‑term growth hinges on successful biotech breakthroughs
  • High geopolitical and currency exposure in China

Key Metrics & Analysis

Financial Health

Revenue Growth-31.90%
Profit Margin-61.78%
ROA-28.97%
P/B Ratio-3.9
Op. Cash Flow$-12904000
Free Cash Flow$-4761625

Technical Analysis

TrendBearish
RSI41.8
Support$1.09
Resistance$1.28
MA 20$1.15
MA 50$1.22
MA 200$1.27
MACDBearish
VolumeDecreasing
Fear & Greed Index91.18

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.78
Volatility44.00%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.